Suppr超能文献

静脉注射后猪体内磺胺甲恶唑/甲氧苄啶制剂的药代动力学

Pharmacokinetics of a sulphamethoxazole/trimethoprim formulation in pigs after intravenous administration.

作者信息

Nouws J F, Vree T B, Degen M, Mevius D

机构信息

Clinical Pharmacy, St. Radboud Hospital, Nijmegen, The Netherlands.

出版信息

Vet Q. 1991 Jul;13(3):148-54. doi: 10.1080/01652176.1991.9694300.

Abstract

Plasma disposition, metabolism, protein binding and renal clearance of sulphamethoxazole (SMZ) and trimethoprim (TMP) were studied in four pigs after intravenous administration at a dose of 40 and 8 mg/kg, respectively. SMZ and TMP were quickly eliminated (mean elimination half-lives: 2.7 and 2.4 h, respectively). SMZ was predominantly acetylated; no hydroxy and glucuronide derivates could be detected in plasma and urine. TMP was 0-demethylated into 4-hydroxytrimethoprim (M1) and 3-hydroxytrimethoprim (M4) metabolite and subsequently extensively glucuronidated. SMZ, TMP and its M1 metabolite were excreted predominantly by glomerular filtration, while N4-acetylsulphamethoxazole and glucuronide conjugates of the M1 and M4 metabolites of TMP were actively eliminated by tubular secretion. The proportional drug percentage being present in the urine as parent compound was 13.1% for TMP and 16.0% for SMZ. The glucuronide conjugates of the M1 and M4 metabolites formed the main part (81.5%) of urinary TMP excretion pattern.

摘要

分别以40毫克/千克和8毫克/千克的剂量对4头猪静脉注射磺胺甲恶唑(SMZ)和甲氧苄啶(TMP)后,研究了它们在血浆中的处置、代谢、蛋白结合及肾脏清除情况。SMZ和TMP被快速消除(平均消除半衰期分别为2.7小时和2.4小时)。SMZ主要发生乙酰化;在血浆和尿液中未检测到羟基和葡萄糖醛酸衍生物。TMP经0-去甲基化生成4-羟基甲氧苄啶(M1)和3-羟基甲氧苄啶(M4)代谢物,随后大量葡萄糖醛酸化。SMZ、TMP及其M1代谢物主要通过肾小球滤过排泄,而TMP的N4-乙酰磺胺甲恶唑以及M1和M4代谢物的葡萄糖醛酸结合物则通过肾小管分泌被主动清除。以母体化合物形式存在于尿液中的药物比例,TMP为13.1%,SMZ为16.0%。M1和M4代谢物的葡萄糖醛酸结合物构成了尿液中TMP排泄模式的主要部分(81.5%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验